Increased sympathetic nerve activity in COPD is associated with morbidity and mortality

Lung

Volumn 192, Issue 2, 2014, Pages 235-241

  Andreas, Stefan ^a,b   Haarmann, Helge ^a   Klarner, Stephan ^a   Hasenfuß, Gerd ^a   Raupach, Tobias ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Lungenfachklinik Immenhausen   (Germany)

Author keywords

Chronic obstructive lung disease; Follow up; Morbidity; Mortality; Prognosis; Sympathetic activity

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ADULT; ADVERSE OUTCOME; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; MUSCLE SYMPATHETIC NERVE ACTIVITY; PRIORITY JOURNAL; REGISTRATION; SYMPATHETIC TONE; TIME OF DEATH;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HOSPITALIZATION; HUMANS; LUNG; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PERONEAL NERVE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 84896929313     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9544-7     Document Type: Article

References (48)

1. Decramer M, Janssens W, Miravitlles M (2012) Chronic obstructive pulmonary disease. Lancet 379:1341-1351
2. Sin DD, MacNee W (2013) Chronic obstructive pulmonary disease and cardiovascular diseases: a "vulnerable" relationship. Am J Respir Crit Care Med 187:2-4
3. Stone IS, Barnes NC, Petersen SE (2012) Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease? Heart 98:1055-1062
4. Fabbri LM, Luppi F, Beghe B et al (2008) Complex chronic comorbidities of COPD. Eur Respir J 31:204-212
5. Raupach T, Bahr F, Herrmann P et al (2008) Slow breathing reduces sympathoexcitation in COPD. Eur Respir J 32:387-392
6. Andreas S, Anker SD, Scanlon PD et al (2005) Neurohumoral activation as a link to systemic manifestation of chronic lung disease. Chest 128:3618-3624 (Pubitemid 41698701)
7. Macnee W, Maclay J, McAllister D (2008) Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:824-833
8. Fatouleh R, Macefield VG (2011) Respiratory modulation of muscle sympathetic nerve activity is not increased in essential hypertension or chronic obstructive pulmonary disease. J Physiol 589:4997-5006
9. Floras JS (2009) Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 54:375-385
10. McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787-1847
11. Swedberg K, Eneroth P, Kjekshus J et al (1990) Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 82:1730-1736 (Pubitemid 20367976)
12. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007-2018
13. Heindl S, Lehnert M, Criée CP et al (2001) Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 164:597-601 (Pubitemid 32801663)
14. Pauwels RA, Buist AS, Ma P et al (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization global initiative for chronic obstructive lung disease (GOLD): executive summary. Respir Care 46:798-825 (Pubitemid 33759920)
15. Ferguson DW, Berg WJ, Sanders JS (1990) Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 16:1125-1134 (Pubitemid 20378462)
16. Wallin BG, Esler M, Dorward P et al (1992) Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol Lond 453:45-58
17. Heindl S, Dodt C, Krahwinkel M et al (2001) Short term effect of continuous positive airway pressure on muscle sympathetic nerve activity in patients with chronic heart failure. Heart 85:185-190 (Pubitemid 32973591)
18. Andreas S, Reiter H, Luthje L et al (2004) Differential effects of theophylline on sympathetic excitation, hemodynamics, and breathing in congestive heart failure. Circulation 110:2157-2162 (Pubitemid 39372494)
19. Shih HT, Webb CR, Conway WA et al (1988) Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 94:44-48
20. Jensen MT, Marott JL, Lange P et al (2012) Resting heart rate is a predictor of mortality in chronic obstructive pulmonary disease. Eur Respir J 42(2):341-349
21. Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577-585 (Pubitemid 29384167)
22. Jouven X, Empana JP, Escolano S et al (2009) Relation of heart rate at rest and long-term ([20 years) death rate in initially healthy middle-aged men. Am J Cardiol 103:279-283
23. Calverley PM, Anderson JA, Celli B et al (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356:775-789 (Pubitemid 46294610)
24. Tashkin DP, Celli B, Senn S et al (2008) A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359:1543-1554
25. Rutten FH, Hoes AW (2012) Chronic obstructive pulmonary disease: a slowly progressive cardiovascular disease masked by its pulmonary effects? Eur J Heart Fail 14:348-350
26. Van Eeden S, Leipsic J, Paul Man SF et al (2012) The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med 186:11-16
27. Borovikova LV, Ivanova S, Zhang M et al (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458-462 (Pubitemid 30367422)
28. Barretto AC, Santos AC, Munhoz R et al (2009) Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. Int J Cardiol 135:302-307
29. Munhoz RT, Negrao CE, Barretto AC et al (2009) Microneurography and venous occlusion plethysmography in heart failure: correlation with prognosis. Arq Bras Cardiol 92:46-53
30. Heistad DD, Wheeler RC, Mark AL et al (1956) Effects of adrenergic stimulation on ventilation in man. Clin Invest 51(6):1469-1475
31. Coats AJ, Adamopoulos S, Radaelli A et al (1992) Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 85:2119-2131
32. Anker SD, Coats AJ (1999) Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115:836-847 (Pubitemid 29129969)
33. Packer M (1992) The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20:248-254
34. Somers VK, Anderson EA, Mark AL (1993) Sympathetic neural mechanisms in human hypertension. Curr Opin Nephrol Hypertens 2:96-105
35. Hofford JM, Milakofsky L, Vogel WH et al (1990) The nutritional status in advanced emphysema associated with chronic bronchitis. A study of amino acid and catecholamine levels. Am Rev Respir Dis 141:902-908 (Pubitemid 20157717)
36. Francis GS, McDonald KM, Cohn JN (1993) Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention. Circulation 87:IV90-IV96 (Pubitemid 23135655)
37. Dinenno FA, Jones PP, Seals DR et al (2000) Age-associated arterial wall thickening is related to elevations in sympathetic activity in healthy humans. Am J Physiol Heart Circ Physiol 278:H1205-H1210 (Pubitemid 30235497)
38. Swierblewska E, Hering D, Kara T et al (2010) An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertens 28:979-984
39. Laurent S, Cockcroft J, Van Bortel L et al (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588-2605 (Pubitemid 44627304)
40. Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318-1327
41. McAllister DA, Maclay JD, Mills NL et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176:1208-1214 (Pubitemid 350256474)
42. Maclay JD, McAllister DA, Mills NL et al (2009) Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180:513-520
43. Sabit R, Bolton CE, Edwards PH et al (2007) Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175:1259-1265 (Pubitemid 46905751)
44. Etminan M, Jafari S, Carleton B et al (2012) Beta-blocker use and COPD mortality: a systematic review and meta-analysis. BMC Pulm Med 12:48
45. Yucha CB (2000) Use of microneurography to evaluate sympathetic activity in hypertension: a brief review. Appl Psychophysiol Biofeedback 25:55-63
46. Jennings GL (1998) Noradrenaline spillover and microneurography measurements in patients with primary hypertension. J Hypertens Suppl 16:S35-S38
47. Hagbarth KE (2002) Microelectrode recordings from human peripheral nerves (microneurography). Muscle Nerve Suppl 11:S28-S35
48. Cohen J (1992) A power primer. Psychol Bull 112:155-159